JP2004500553A5 - - Google Patents

Download PDF

Info

Publication number
JP2004500553A5
JP2004500553A5 JP2001528702A JP2001528702A JP2004500553A5 JP 2004500553 A5 JP2004500553 A5 JP 2004500553A5 JP 2001528702 A JP2001528702 A JP 2001528702A JP 2001528702 A JP2001528702 A JP 2001528702A JP 2004500553 A5 JP2004500553 A5 JP 2004500553A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001528702A
Other languages
Japanese (ja)
Other versions
JP2004500553A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/027682 external-priority patent/WO2001025791A2/en
Publication of JP2004500553A publication Critical patent/JP2004500553A/ja
Publication of JP2004500553A5 publication Critical patent/JP2004500553A5/ja
Pending legal-status Critical Current

Links

JP2001528702A 1999-10-07 2000-10-06 前立腺ガンのマーカータンパク質 Pending JP2004500553A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15842299P 1999-10-07 1999-10-07
PCT/US2000/027682 WO2001025791A2 (en) 1999-10-07 2000-10-06 Prostate cancer marker proteins

Publications (2)

Publication Number Publication Date
JP2004500553A JP2004500553A (ja) 2004-01-08
JP2004500553A5 true JP2004500553A5 (enExample) 2005-12-15

Family

ID=22568045

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001528702A Pending JP2004500553A (ja) 1999-10-07 2000-10-06 前立腺ガンのマーカータンパク質

Country Status (7)

Country Link
EP (1) EP1224466B1 (enExample)
JP (1) JP2004500553A (enExample)
AT (1) ATE350662T1 (enExample)
AU (1) AU7868300A (enExample)
CA (1) CA2386669A1 (enExample)
DE (1) DE60032784T2 (enExample)
WO (1) WO2001025791A2 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1426536A (zh) * 2000-03-20 2003-06-25 东弗吉尼亚医学院 前列腺癌标记
AUPQ886100A0 (en) * 2000-07-19 2000-08-10 Biotron Limited Diagnostic test
GB2379737A (en) * 2001-09-05 2003-03-19 Univ Geneve Diagnostic method for spongiform encephalopathy disease
CA2477035A1 (en) * 2002-02-21 2003-09-04 Eastern Virginia Medical School Protein biomarkers that distinguish prostate cancer from non-malignant cells
EP2211181A1 (en) 2002-10-30 2010-07-28 Proteome Sciences Plc Diagnostic method for transmissible spongiform encephalopathies
ATE502300T1 (de) 2002-12-26 2011-04-15 Nitto Boseki Co Ltd Immunoassay-verfahren
CA2526878A1 (en) 2003-04-08 2004-10-21 Colotech A/S A method for detection of colorectal cancer in human samples
US7425700B2 (en) 2003-05-22 2008-09-16 Stults John T Systems and methods for discovery and analysis of markers
JP4568551B2 (ja) * 2004-07-28 2010-10-27 一晃 掛樋 糖たん白質糖鎖の分析方法及び非標識糖鎖の製造方法
JP2008537112A (ja) * 2005-04-07 2008-09-11 モザイクヴェス ディアグノシュティクス アンド テラポイティクス アクチェン ゲゼルシャフト 前立腺がんの診断のためのポリペプチドマーカー
CN101454331A (zh) * 2006-03-24 2009-06-10 菲诺梅诺米发现公司 有效用于诊断前列腺癌的生物标记,及其方法
GB0617429D0 (en) 2006-09-05 2006-10-18 Electrophoretics Ltd Markers of renal transplant rejection and renal damage
EP2012127A3 (en) * 2007-07-03 2009-03-11 Koninklijke Philips Electronics N.V. Diagnostic markers for detecting prostate cancer
JP2013528379A (ja) * 2010-05-21 2013-07-11 オームクス コーポレーション Psa酵素活性アッセイによる癌の検出
US20140134658A1 (en) * 2010-05-21 2014-05-15 Notrhwestern University, An Illinois Not For Profit Corporation Psa enzymatic activity: a new biomarker for assessing prostate cancer aggressiveness
JP6047150B2 (ja) 2011-05-13 2016-12-21 キングス・カレッジ・ロンドン 血小板感受性に関係する方法と組成物
WO2015042493A2 (en) * 2013-09-20 2015-03-26 Ohmx Corporation Psa enzymatic activity: a new biomarker for assessing prostate cancer aggressiveness
CA3146525A1 (en) 2019-08-05 2021-02-11 William Manning Systems and methods for sample preparation, data generation, and protein corona analysis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5866679A (en) * 1994-06-28 1999-02-02 Merck & Co., Inc. Peptides
US6143864A (en) * 1994-06-28 2000-11-07 Merck & Co., Inc. Peptides
US5807978A (en) * 1995-06-07 1998-09-15 Kokolus; William J. Immunogenic peptides of prostate specific antigen
CA2284137A1 (en) * 1997-03-11 1998-09-17 Sloan Kettering Institute For Cancer Research Prostate specific antigen substrates
US6207370B1 (en) * 1997-09-02 2001-03-27 Sequenom, Inc. Diagnostics based on mass spectrometric detection of translated target polypeptides
US6300088B1 (en) * 1997-11-24 2001-10-09 Duke University Method of detecting prostate specific antigen
WO1999037811A1 (en) * 1998-01-21 1999-07-29 Urocor, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate disease
JP2002516082A (ja) * 1998-05-29 2002-06-04 インサイト・ファーマスーティカルズ・インコーポレイテッド ヒト膜貫通タンパク質

Similar Documents

Publication Publication Date Title
BE2017C009I2 (enExample)
BE2016C018I2 (enExample)
BE2014C035I2 (enExample)
BE2013C060I2 (enExample)
BE2012C016I2 (enExample)
BE2011C032I2 (enExample)
BE2010C018I2 (enExample)
BRPI0113085B8 (enExample)
BE2011C041I2 (enExample)
AU2000236813A8 (enExample)
CN300955183S (zh) 连接件
BR122012015772A2 (enExample)
JP2001216433A5 (enExample)
AU2001294354A8 (enExample)
CN3135584S (enExample)
CN3139578S (enExample)
AU2000280319A8 (enExample)
AU2000280296A8 (enExample)
AU2000278679A8 (enExample)
AU2000278563A8 (enExample)
AU2000278560A8 (enExample)
AU2000264849A8 (enExample)
BY4905C1 (enExample)
CL2001002979A1 (enExample)
AU2000256911A8 (enExample)